The Food and Drug Administration, facing increased criticism of its regulatory process for gene-edited animals, is mounting a new effort to defend its policies to farmers, researchers and developers, ...
PHILADELPHIA, Oct. 16, 2025/PRNewswire/ -- As infectious disease leaders gather in Atlanta for IDWeek 2025 (October 19–22), Philadelphia-based biotech, LIV Process is shining a light on one of ...
As pharmaceutical manufacturing grows increasingly complex, Merck KGaA wants to ramp up its development capabilities for clinical trial compounds. The German life sciences company got one step closer ...